|
Product analysis #705178434:¿ equipment used: vis (m-81805), 203cm ruler (m-83360) ¿ drawing(s) referenced: none ¿ as found condition: the solitaire platinum revascularization device was returned for analysis within a shipping box and within a plastic bio-pouch.¿ visual inspection/damage location details: the solitaire platinum revascularization device was returned within its introducer sheath.The marker coil was found bent within the introducer sheath.In addition, the stent non-working length struts were found bent within the introducer sheath.The solitaire platinum revascularization device was pulled out from within the introducer sheath for further evaluation.The stent attachment zone was found in good condition.The stent non-working length struts were found bent and the tear drop strut was found broken.The stent working length struts were found in good condition.¿ testing/analysis: none ¿ conclusion: based on the device analysis and reported information, the customer¿s ¿resistance¿ report was confirmed.Damage to the solitaire platinum revascularization device (stent strut bent/broken, marker coil bent) can occur if the device is advanced/retrieved against resistance.Possible causes of resistance/stuck during delivery include use of an incompatible catheter, catheter damage, patient vessel tortuosity, or user does not maintain continuous flush.The rebar-027 micro catheter is compatible for use with the solitaire platinum revascularization device and the patient¿s vessel tortuosity was ¿moderate¿.However, the rebar-027 micro catheter was not returned.Therefore, an analysis could not be performed and conformance to specification could not be assessed.Information regarding if a continuous flush of the rebar-027 micro catheter was maintained was not reported.The cause of the reported resistance could not be determined.(rosaj10 2022-10-13) medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Medtronic received information that an sfr3 solitaire stent had resistance in the distal section of the rebar-27 catheter during del ivery.On (b)(6) 2022, the physician was performing an interventional thrombectomy and opening surgery for acute large blood vessel occlusion.During the surgery, after the guidewire with microcatheter rebar-27 were inplace.Under the circumstance that sfr3-6- 40-10 product did not enter the body and after being delivered to the tail of the microcatheter by the stent protective sheath, it became stuck and it was difficult to continue to be delivered.The surgeons in order to make the surgery safe, and after trying 2 times without success, the stent was selected to be replaced.Since the 6-40 stent was out of stock, the sfr3-4-40-10 stent was chosen to perform the surgery, and the surgery was successfully completed.The patient was being treated for an ischemic stroke in the middle cerebral artery. mrs: baseline 2.Mrs: procedure 1.Nihss score: baseline 15.Nihss score: post procedure 3.Tici score: baseline 0.Tici score: post procedure 2b.Iv tpa was not contraindicated.1 pass was made with the device.Vessel tortuosity was moderate.No patient symptoms or complications were reported.
|